-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $98

Benzinga·12/16/2025 17:27:48
Listen to the news
Stifel analyst Dae Gon Ha maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and raises the price target from $92 to $98.